The efficacy and the safety of eltrombopag in pediatric patients with severe aplastic anemia: a systematic review

• Κύριοι συγγραφείς: Maria Maddalena Marrapodi (Συγγραφέας), Annamaria Mascolo (Συγγραφέας), Domenico Roberti (Συγγραφέας), Martina Di Martino (Συγγραφέας), Concetta Rafaniello (Συγγραφέας), Consiglia Riccardi (Συγγραφέας), Francesca Rossi (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2023-04-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

BackgroundAcquired aplastic anemia (AAA) in pediatric patients is a rare disorder characterized by hypocellular bone marrow and pancytopenia. Eltrombopag, an oral thrombopoietin receptor agonist, provides a hematologic improvement in adults with severe aplastic anemia (SAA) refractory to immunosuppr...